At ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, ground-breaking cancer research is every-day reality. The Graham Cancer Center brings scientists and clinicians together to investigate innovative ways to diagnose cancer earlier and treat it more effectively.
Because of its membership in the prestigious National Cancer Institute NCI Community Oncology Research Program (NCORP), the Graham Cancer Center offers leading-edge NCORP clinical trials to the patients we are privileged to serve. The Graham Cancer Center also offers a robust pharmaceutical clinical trials program.
In addition to clinical trials, the Graham Cancer Center has a translational cancer research program, the Cawley Center for Translational Cancer Research (CTCR) that brings scientific discoveries from the bench to the bedside of patients, investigating breast cancer, colon cancer, radiation oncology and tissue engineering. The Graham Cancer Center conducts industry-leading genetic engineering cancer research at the Gene Editing Institute.
The Graham Cancer Center collaborates with other institutions in cancer research, having close partnerships with The Wistar Institute, the University of Delaware, Nemours / A.I. du Pont Hospital for Children, Rice University / BioScience Research Collaborative and the Delaware Biotechnology Institute, among others.
The mere thought of breast cancer strikes fear in every woman, regardless of race, culture or socioeconomic background.
Exploring solutions in the lab and translate those results directly into treatment plans as unique as the individuals who will benefit from them.
The goal of the research is to identify cancer stem cell-based targets that will lead to the development of curative treatment for patients.
Research focusing on new plasma and tissue biomarkers to improve early diagnosis and clinical management of epithelial ovarian cancer.
The mission of the Radiation Oncology Department at the Helen F. Graham Cancer Center is to serve our neighbors and provide state-of-the-art, safe therapy care.
All biomedical and behavioral research protocols are reviewed and approved by the ChristianaCare Institutional Review Board in accordance with 21 CFR 50 and 45
Our partnerships are a magnet for life science research and development.
An outreach to Salivary Gland Surgeons & Researchers to join ongoing projects or to develop new projects and link to interested researchers.
The Tissue Procurement Center (TPC) at the Helen F. Graham Cancer Center & Research Institute was established in 2003.